Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > FDA approval

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Mar 07, 2024 4:07pm

54 Views

Post# 35921336

RE:RE:FDA approval

Thanks MDJ, but still under water on MMED tho...lol. It's the retail investors that always end up holding the bag. I've grown wiser and just invest in ETFs with nice dividends now. Reverse splits are the devil and I hope LABS doesn't take that route. I've been with LABS since the IPO and also believe good things are ahead after the pivot from three years ago. It's going to take some time and the reward may not be as big as some on here think but patience will pay off on this one.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario